Evidence map›Paper›PMID 37857338›Full record

ArticleEpidemiology and health2023

Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort.

Rilwan Azeez, Larisa Lotoski, Aimée Dubeau, Natalie Rodriguez, Myrtha E Reyna, Tyler Freitas, Stephanie Goguen, Maria Medeleanu, Geoffrey L Winsor, Fiona S L Brinkman and 18 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. From Fetus to Eight: the CHILD Cohort Study.American journal of epidemiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 2 countries.

Rilwan AzeezDepartment of Immunology, University of Manitoba, Winnipeg, MB, Canada.
Larisa LotoskiChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Aimée DubeauDivision of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Natalie RodriguezChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Myrtha E ReynaDivision of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Tyler FreitasDepartment of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Stephanie GoguenChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Maria MedeleanuDivision of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Geoffrey L WinsorDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
Fiona S L BrinkmanDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
Emily E CameronDepartment of Psychology, University of Manitoba, Winnipeg, MB, Canada.
Leslie RoosChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Elinor SimonsChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Theo J MoraesDivision of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Piush J MandhaneDepartment of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Stuart E TurveyDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Shelly BolotinCentre for Vaccine Preventable Diseases, University of Toronto; Dalla Lana School of Public Health, University of Toronto; Department of Laboratory Medicine and Pathobiology, University of Toronto; Public Health Ontario, ON, Canada.
Kim WrightDepartment of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Deborah McNeilDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
David M PatrickSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Jared BullardChildren's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
Marc-André LangloisDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Corey R ArnoldDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Yannick GalipeauDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Martin PelchatDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Natasha DoucasCHILD Cohort Study National Parent Engagement Committee.
Padmaja SubbaraoDivision of Respiratory Medicine, Department of Pediatrics and Program in Translational Medicine, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Meghan B AzadDepartment of Immunology, University of Manitoba, Winnipeg, MB, Canada.
Manitoba Health · CAChildren's Hospital Research Institute of Manitoba · CASickKids Foundation · CAMcMaster University · CASimon Fraser University · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected all Canadian families, with some impacted differently than others. Our study aims to: (1) determine the prevalence and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among Canadian families, (2) identify predictors of infection susceptibility and severity of SARS-CoV-2, and (3) identify health and psychosocial impacts of the COVID-19 pandemic. This study builds upon the CHILD Cohort Study, an ongoing multi-ethnic general population prospective cohort consisting of 3,454 Canadian families with children born in Vancouver, Edmonton, Manitoba, and Toronto between 2009 and 2012. During the pandemic, CHILD households were invited to participate in the CHILD COVID-19 Add-On Study involving: (1) brief biweekly surveys about COVID-19 symptoms and testing; (2) quarterly questionnaires assessing COVID-19 exposure and testing, vaccination status, physical and mental health, and pandemic-driven life changes; and (3) in-home biological sampling kits to collect blood and stool. In total, 1,462 households (5,378 participants) consented to the CHILD COVID-19 Add-On Study: 2,803 children (mean±standard deviation [SD], 9.0±2.7 years; range, 0-17 years) and 2,576 adults (mean±SD, 43.0±6.5 years; range, 18-85 years). We will leverage the wealth of pre-pandemic CHILD data to identify risk and resilience factors for susceptibility and severity to the direct and indirect pandemic effects. Our short-term findings will inform key stakeholders and knowledge users to shape current and future pandemic responses. Additionally, this study provides a unique resource to study the long-term impacts of the pandemic as the CHILD Cohort Study continues.

Indexed as

COVID-19Psychological DistressAdultCanadaCohort StudiesHumansPandemicsProspective StudiesSARS-CoV-2Cohort studiesCOVID-19EpidemiologyImmunologyPediatricsSARS-CoV-2

Identifiers

PMID37857338
PMCPMC10867514
OpenAlexW4387669851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.